Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.14% to 10743.35, DAX (0.14%) to 26091.33, CAC40 (0.09%) to 8501.91, STOXX 600 (0.11%) to 651.16

Aug 19 ,2026

  • Synopsis:

    • European equity markets closed mostly mixed to lower, with FTSE100 faring better. Follows Tuesday's weaker close. Basic resources, healthcare, chemicals, and autos the best performers; banks, insurance, and utitlities main laggards.

    • Speaking at the WEF International Business Council, ECB President Lagarde highlighted that energy costs for European industry are more than twice as high as in the US and ~50% higher than in China, following the loss of cheap Russian energy. Stressed need for stronger domestic demand, reduce market fragmentation and boost investment in AI and innovation. In UK, PM Burnham said Chancellor Healey will give major speech on government's economic agenda next month. Meanwhile, economists warned on need for cautious UK fiscal policy amid bond market volatility.

    • On the macro calendar, Eurozone final CPI unchanged from flash at 2.9% y/y, core 2.5% y/y. Earlier, UK inflation accelerated in July, as expected. Headline CPI at 2.9% y/y versus consensus 2.9% and prior 2.6%, while core inflation at 2.6% versus 2.5% forecast and prior 2.6% and services prices met expectations with 3.4% reading from prior 3.6%. It was the highest headline inflation rate since March. Survey from UK HR data provider Brightmine showed pay growth easing to 10 month low.

    • In earnings news, Carlsberg (CARL.B.DC) reported solid H1 earnings and narrowed its FY operating profit growth guidance to the upper end of its range, while FLSmidth (FLS.DC) also issued a positive Q2 update and upgraded its FY margin and organic revenue outlook. In Benelux, ASR Nederland (ASRNL.NA) beat H1consensus estimates and raised its interim dividend by 9.4%. In DACHs, Geberit (GEBN.SW) and Straumann (STMN.SW) both posted beats, with Geberit guiding 5-6% FY sales growth and Straumann reaffirming its upgraded profitability outlook. Sunrise Communications (SUNN.SW) beat Q2 and reconfirmed FY guidance. In the UK, Ithaca Energy (ITH.LN) provided upbeat interim update, lowered cost guidance and upgraded shareholder return targets, with the Rosebank project on track for first production in H1 2027.

    • On the M&A newsflow, IlSole24Ore reported that Banca Monte dei Paschi di Siena (BMPS.IM) CEO Lovaglio is considering a dual bids for Banco BPM (BAMI.IM), Banca Generali (BGN.IM) to counter Intesa Sanpaolo (ISP.IM) exchange offer, with board meeting called for tomorrow morning. Elsewhere, Ridgeview Partners made a recommended 448p/share in cash offer to acquire Pinewood Technologies Group (PINE.LN), valuing the company ~£545M on a fully diluted basis.

    • Looking ahead to tomorrow's EU econ-calendar, key releases will include, amongst others, Germany Jul PPI, Eurozone Jun construction output, UK Aug industrial trends orders - CBI, and Switzerland Jul trade balance (monthly watch stats).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +3.30%, Health Care +1.35%, Chemicals +1.09%, Autos & Parts +1.08%, Retail +0.94%, Construct & Mtls +0.83%, Persnl & HHold Goods +0.56%, Oil & Gas +0.54%, Telecom +0.37%, Real Estate +0.08%, Food & Beverage +0.07%, Travel & Leisure +0.06%, Financial Svcs +0.02%, Media +0.01%

      • Underperformers:

        • Banks (1.50%), Insurance (1.14%), Utilities (1.10%), Technology (0.62%), Ind Goods & Svcs (0.48%)

    • Macro:

      • Central banks:

        • Panel remarks about the European economy during a discussion on the global economic outlook at the World Economic Forum -- ECB

      • EU:

        • Record Pace of Bond Sales Jolts Europe Out of Summer Lull -- Bloomberg

      • UK:

        • UK relies on heat-stressed countries for fruit and veg it could grow itself - report -- Guardian

        • Tackling NHS Inefficiency Could Save Britain £32B -- Bloomberg

      • Germany:

        • Germany gears up for upcoming state elections -- Reuters

    • Company news:

      • Notable Gainers

        • +24.7% SUS.SS (Surgical Science Sweden SEK48.24, +9.66) -- earnings

        • +16.4% BOUV.NO (Bouvet NOK48.60, +7.10) -- earnings

        • +13.7% PION.B.SS (PION Group SEK6.44, +0.80) -- earnings

        • +13.5% AMBEA.SS (Ambea AB SEK165.50, +19.70) -- earnings

        • +13.4% ONT.LN (Oxford Nanopore Technologies £1.38, +0.16) -- earnings

        • +13.2% BICO.SS (BICO Group SEK19.24, +2.20) -- earnings; CEO steps down

        • +9.2% EBUS.NA (Ebusco Holding €0.25, +0.02) -- Equity invests 6M

        • +7.4% GEBN.SW (Geberit CHF569.00, +39.20) -- earnings

        • +7.3% SYNACT.SS (SynAct Pharma SEK22.00, +1.45) -- first commercial agreementon resomelagon for treatment of dengue in Brazil

        • +6.4% LLBN.SW (Liechtensteinische Landesbank CHF115.40, +7.00) -- earnings

        • +6.3% IMPN.SW (Implenia CHF67.30, +4.00) -- earnings

        • +6.3% FLS.DC (FLSmidth & Co. DKK524.50, +31.30) -- earnings

        • +5.8% DR0.GR (Deutsche Rohstoff €98.50, +5.40) -- earnings

        • +5.7% KMR.LN (Kenmare Resources £2.08, +0.11) -- earnings

        • +5.5% NANO.LN (Nanoco Group £0.03, -0.00) -- trading update

        • +4.8% BEWI.NO (Bewi ASA NOK22.00, +1.00) -- earnings

        • +4.3% EVS.BB (EVS Broadcast Equipment €29.25, +1.20) -- earnings

        • +3.6% FLU.AV (Flughafen Wien €52.20, +1.80) -- earnings

        • +3.4% NOBA.SS (NOBA Bank Group SEK89.80, +3.00) -- target up at Goldman Sachs

        • +2.6% CANTA.SS (Cantargia SEK1.75, +0.04) -- earnings

        • +2.5% ITH.LN (Ithaca Energy £2.59, +0.06) -- earnings

        • +2.5% SEDANA.SS (Sedana Medical SEK10.60, +0.26) -- FDA NDA acceptance for review

        • +1.8% SLR.SM (Solaria Energia €17.10, +0.29) -- BofA upgrade

      • Notable Decliners

        • -23.0% XSPRAY.SS (Xspray Pharma SEK10.88, -3.16) -- receives CRL from FDA for Dasynoc

        • -18.8% AVTX.NA (Avantium €5.82, -1.32) -- earnings; funding update

        • -13.8% TRN.LN (Trainline £2.04, -0.34) -- CMA investigation

        • -10.9% PFSE.GR (PFISTERER Holding €73.00, -8.50) -- earnings

        • -8.2% IDUN.B.SS (Idun Industrier SEK313.00, -28.00) -- earnings

        • -6.7% ALFEN.NA (Alfen €12.73, -0.92) -- earnings

        • -5.6% EG7.SS (Enad Global 7 SEK18.94, -1.12) -- earnings

        • -5.0% ROCK.B.DC (Rockwool DKK207.20, -11.20) -- earnings; raises FY revenue growth

        • -4.7% ULTP.LN (Ultimate Products £0.54, -0.03) -- trading update

        • -4.7% EMMN.SW (Emmi CHF842.00, -41.00) -- earnings

        • -3.9% SN.LN (Smith & Nephew £10.75, -0.43) -- CFO steps down

        • -3.9% FACC.AV (FACC €16.20, -0.66) -- earnings

        • -3.8% ODL.NO (Odfjell Drilling NOK92.80, -3.60) -- Fearnley downgrade

        • -3.8% DOFG.NO (DOF Group NOK132.90, -5.30) -- earnings

        • -3.4% BCHN.SW (Burckhardt Compression Holding CHF501.00, -17.50) -- restructuring measures

        • -3.3% HLUN.B.DC (H. Lundbeck DKK42.50, -1.44) -- earnings; Lundbeckfond Invest launches a voluntary exchange offer to eligible A-shareholders in H. Lundbeck

        • -2.8% IRLAB.A.SS (IRLAB Therapeutics SEK1.70, -0.05) -- drug candidate IRL757 receives WHO generic name Linepemat

        • -2.7% NONG.NO (SpareBank 1 Nord-Norge NOK165.02, -4.58) -- SEB downgrade ( 18-Aug, timing uncertain)

        • -2.5% FRACTL.SS (Fractal Gaming Group SEK14.30, -0.36) -- earnings

        • -2.4% STMN.SW (Straumann Holding CHF96.30, -2.44) -- earnings

        • -2.3% SAFE.LN (Safestore Holdings £5.90, -0.14) -- Deutsche Bank downgrade

        • -2.2% AUSS.NO (Austevoll Seafood NOK83.00, -1.90) -- earnings

        • -2.1% CARL.B.DC (Carlsberg DKK873.80, -19.20) -- earnings

        • -2.0% LINK.NO (LINK Mobility Group Holding NOK25.96, -0.54) -- earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: UNIQA Insurance Group (UQA.AV), Mayr-Melnhof Karton (MMK.AV), SBO (SBO.AV)

        • Belgium: Kinepolis Group (KIN.BB), Deceuninck (DECB.BB), Biotalys (BTLS.BB)

        • Denmark: Novonesis (NSIS.B.DC), ALK-Abello (ALK.B.DC), GN Store Nord (GN.DC), Gubra (GUBRA.DC), SP Group (SPG.DC), Columbus (COLUM.DC), cBrain (CBRAIN.DC), North Media (NORTHM.DC), TCM Group (TCM.DC), BioPorto (BIOPOR.DC)

        • Finland: Nanoform Finland (NANOFH.FH), Rapala VMC (RAP1V.FH)

        • Germany: CTS Eventim (EVD.GR), tonies (TNIE.GR), Nabaltec (NTG.GR), NFON (NFN.GR)

        • Netherlands: Aegon (AGN.NA)

        • Norway: Höegh Autoliners (HAUTO.NO), Odfjell (ODF.NO), Orkla (ORK.NO), Endur (ENDUR.NO), Kid (KID.NO), Panoro Energy (PEN.NO), Nekkar (NKR.NO), Norse Atlantic (NORSE.NO), Vistin Pharma (VISTN.NO), IDEX Biometrics (IDEX.NO), Webstep (WSTEP.NO), Atlantic Sapphire (ASA.NO), Norconsult (NORCO.NO), B2 Impact (B2I.NO)

        • Sweden: Holmen (HOLM.B.SS), Hufvudstaden (HUFV.A.SS), Bure Equity (BURE.SS), Attendo (ATT.SS), New Wave Group (NEWA.B.SS), Karnov Group (KAR.SS), Better Collective (BETCO.SS), Viva Wine Group (VIVA.SS), Fasadgruppen Group (FG.SS), Catella (CAT.B.SS), Medivir (MVIR.SS), SynAct Pharma (SYNACT.SS), Minesto (MINEST.SS), Sensys Gatso Group (SGG.SS), Mendus (IMMU.SS), Greater Than (GREAT.SS), Starbreeze (STAR.B.SS), Active Biotech (ACTI.SS), Ascelia Pharma (ACE.SS)

        • Switzerland: Banque Cantonale Vaudoise (BCVN.SW), Swiss Prime Site (SPSN.SW)

        • UK: Hays (HAS.LN), Capital (CAPD.LN)

      • Trading Update:

        • UK: JD Sports Fashion (JD.LN)

  • Data:

    • Economics:

      • Eurozone Jul CPI +2.9% y/y vs preliminary +2.9%

      • UK Jul

        • CPI +2.9% y/y vs consensus +2.9% and prior +2.6%

        • Output PPI +3.1% y/y vs consensus +3.2% and prior +3.5%

      • Switzerland Q2 Industrial Production +5.5% y/y vs consensus (4.7%) and prior revised (7.6%) from (7.1%)

    • Markets:

      • WTI Crude (26-Sep): +$1.51 or +1.78% to $86.45

      • €-$ +0.0092 or +0.79% to 1.1669

      • £-$ +0.0078 or +0.58% to 1.3611

      • €-£ +0.0018 to 0.8574

      • S&P 500 +0.42%

      • Performance year-to-date:

        • FTSE 100: +8.18%

        • DAX: +6.54%

        • CAC: +4.32%

        • MIB: +17.07%

        • Stoxx 600: +9.96%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.